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ABSTRACT
Regulation of splicing in eukaryotes occurs
through the coordinated action of multiple splicing
factors. Exons and introns contain numerous
putative binding sites for splicing regulatory
proteins. Regulation of splicing is presumably
achieved by the combinatorial output of the binding
of splicing factors to the corresponding binding
sites. Although putative regulatory sites often
overlap, no extensive study has examined whether
overlapping regulatory sequences provide yet
another dimension to splicing regulation. Here we
analyzed experimentally-identified splicing regula-
tory sequences using a computational method
based on the natural distribution of nucleotides
and splicing regulatory sequences. We uncovered
positive and negative interplay between overlapping
regulatory sequences. Examination of these
overlapping motifs revealed a unique spatial distri-
bution, especially near splice donor sites of exons
with weak splice donor sites. The positively selected
overlapping splicing regulatory motifs were highly
conserved among different species, implying
functionality. Overall, these results suggest that
overlap of two splicing regulatory binding sites is
an evolutionary conserved widespread mechanism
of splicing regulation. Finally, over-abundant motif
overlaps were experimentally tested in a reporting
minigene revealing that overlaps may facilitate a
mode of splicing that did not occur in the
presence of only one of the two regulatory
sequences that comprise it.
INTRODUCTION
Splicing is a molecular mechanism by which introns are
removedfromanmRNAprecursorandexonsareligatedto
form a mature mRNA (1). Most human genes that encode
proteins contain multiple introns, and intronic sequence
accountsfor95%oftheaverage28000ntofatranscription
unit (2,3). Introns are variable in length and sequence, and
thus the splicing machinery must be remarkably ﬂexible in
order to correctly recognize and excise all introns.
Splicing, which occurs in organisms as diverse as yeast
and human, takes place within the spliceosome—a large
complex comprising ﬁve small nuclear RNPs (U1, U2, U4,
U5 and U6 snRNP) and as many as 150 proteins (4–7).
The splicing machinery recognizes exons and introns using
multiple signals, which presumably results in a network of
interactions across exons and/or introns (8). Four main
splice signals assist the splicing machinery in recognizing
the proper exon–intron boundaries. These are the 50 and 30
splice sites, located at the 50 and 30 end of introns, and the
branch site and the polypyrimidine tract, which are
located upstream of the 30 splice site (1,9). In metazoans,
splice sites are degenerate and are postulated to provide
only half of the information required for recognition by
the splicing machinery (10,11). Studies of the molecular
basis of splicing revealed the existence of exonic and
intronic cis-acting regulatory sequences (ESRs and ISRs,
respectively) that bind trans-acting factors and inﬂuence
splice-site selection. These cis-acting elements are rela-
tively short, usually 4–12nt, are classiﬁed as exonic or
intronic splicing enhancers or silencers, and are required
for the regulation of both constitutive and alternative
splicing (12–17). Speciﬁc binding of splicing regulatory
proteins (such as SR and hnRNP proteins) to these
splicing regulatory elements assists in the placement of
the spliceosome on the appropriate splice sites (18,19).
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transcript is generated from the same mRNA precursor,
giving rise to functionally diﬀerent proteins (20). This
requires that exons and introns be deﬁned diﬀerently
within the same sequence context (1,9,21). Thus, alterna-
tive splicing is a fundamental aspect of post-
transcriptional gene regulation with signiﬁcant functional
implications.
The regulation of splicing in eukaryotes is highly
complex and often takes place through the coordinated
action of multiple splicing regulatory factors. Smith and
Valcarcel previously suggested that splicing is regulated
by the combinatorial outcome of several regulatory
sequences (22) and this hypothesis now has experimental
support (23). A recent study examined the tendency of
splicing factors to bind cooperatively (24); however, no
extensive bioinformatic studies have examined whether
overlapping regulatory sequences exhibit unique functions
and provide another dimension to splicing regulation. For
example, overlapping regulatory binding motifs may
modulate exon selection by serving as a template for a
competitive inhibition between two diﬀerent SR
proteins. The outcome of such competition may depend
on the strength with which each protein binds to its
speciﬁc regulatory sequence or on the expression levels
of the corresponding SR proteins, their level of
phosphorylation, or their spatial distribution within the
cell (Figure 1). This could provide another dimension
for splicing regulation. This type of mechanism is known
to occur during the regulation of transcription, which is
aﬀected by the binding of diﬀerent transcription factors to
overlapping binding motif sequences (25–28). The use of
several splicing regulatory overlapping motifs in a
combinatorial fashion could allow cells to express the
required amount of each splice variant at the proper time.
Here we describe a bioinformatic method, based on the
natural distribution of nucleotides and splicing regulatory
sequences, which indicates that there is a positive and
negative interplay between overlapping splicing regulatory
sequences. Speciﬁcally, we found 72 splicing regulatory
motifs that overlapped more than expected and 153
splicing regulatory motif overlaps that were under
negative selection. Examination of these motif overlaps
revealed a unique spatial distribution; they tend to be
found near the 50 splice sites of exons, especially in
exons with weak 50 splice sites. Moreover, the
over-abundant overlapping motifs are highly conserved
among diﬀerent species, implying functionality. As a
proof of principle, we experimentally tested the eﬀect of
the signiﬁcantly over-abundant motif overlaps on the
splicing pattern in a reporting minigene system. The
results revealed that the overlaps facilitated a mode of
splicing that did not occur in the presence of only one of
the two regulatory sequences that comprise it, nor did it
occur in the absence of the entire overlap. Overall, the
results we present suggest that overlapping splicing regu-
latory motifs provide another dimension of splicing
regulation.
MATERIAL AND METHODS
Dataset compilation
Exonic and intronic sequences of human (hg18), mouse
(mm9), rat (rn4), dog (canFam2), chicken (gal3) and
zebraﬁsh (danRer5) RefSeq genes were extracted from
tables in the UCSC genome browser (http://www
.genome.ucsc.edu/) (29) using GALAXY (http://main.g2
.bx.psu.edu/) (30). Orthologous exons were identiﬁed
using coordinates downloaded from the UCSC genome
browser. In order to obtain reliable alignments, we
included only orthologous exons of the same length with
identity levels higher than 75%.
Construction of the SXN-derived minigenes
The overlapping regulatory motifs and its mutants were
cloned into SalI and BamHI sites inside the SXN
reporting exon using the following oligos by annealing:
50-TCG ATG TTT GCG GCT GCT GGA ATG-30 and
50-GAT CCA TTC CAG CAG CCG CAA ACA-30;
50-TCG ATG TTA AGG GCT GCT GGA ATG-30 and
50-GAT CCA TTC CAG CAG CCC TTA ACA-30;
50-TCG ATG TTT GCG GCA AAA GGA ATG-30 and
50-GAT CCA TTC CTT TTG CCG CAA ACA-30;
50-TCG ATG TTA AGG GCA AAA GGA ATG-30 and
50-GAT CCA TTC CTT TTG CCC TTA ACA-30;5 0-TCG
ATG TTC GCG GAG GAG AAT G-30 and 50-GAT
CCA TTC TCC TCC GCG AAC A-30;5 0-TCG ATG
TTC TCG GAG GAG AAT G-30 and 50-GAT CCA
TTC TCC TCC GAG AAC A-30;5 0-TCG ATG TTC
GCG GAT CAG AAT G-30 and 50-GAT CCA TTC
Figure 1. Possible outcomes of overlapping regulatory sequences. As an example, a potential overlap between the binding sites of SRp55 (dark gray
ellipse) and SF2 (light gray ellipse) is illustrated. A speciﬁc cell type or a cell at a speciﬁc time where (A) SF2 expression is down-regulated resulting
in binding of SRp55 to its binding site, (B) SRp55 expression is down-regulated resulting in binding of SF2 to its binding site, (C) both SF2 and
SRp55 are expressed at signiﬁcant levels and compete with each other for binding to their overlapping regulatory sequences.
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GAT CAG AAT G-30 and 50-GAT CCA TTC TGA
TCC GAG AAC A-30; All plasmids were conﬁrmed by
DNA sequencing.
Transfection, RNA isolation and RT-PCR ampliﬁcation
The 293T cell line was cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM), supplemented with 4.5g/ml
glucose (Renium) and 10% fetal calf serum (Biological
Industries). Cells were grown to 50% conﬂuence in a
10-cm culture dish, under standard conditions, at 37 C
with 5% CO2. Cells were split at a 1:8 ratio to 6-well
plates 24h prior to transfection. Transfection was per-
formed using 3ml of FuGENE6 (Roche) with 1mg
of plasmid DNA. Cells were harvested 48h
post-transfection. Total cytoplasmic RNA was extracted
using TriReagent (Sigma), followed by treatment with 2U
of RNase–free DNase (Ambion). Reverse transcription
(RT) was performed on 2mg of total cytoplasmic RNA
for 1h at 42 C, using an oligo(dT) and 2U of reverse
transcriptase of avian myeloblastosis virus (RT-AMV,
Roche). The spliced cDNA products derived from the
expressed minigenes were detected by PCR, using
vector-speciﬁc primers: 50-ATC GAT CCT GCA CCT
GAC TC-30 and 50-CAG CAT CAG GAG TGG ACA
GA-30. Ampliﬁcation was performed for 30 cycles, consist-
ing of 94 C for 30s, 60 C for 45s and 72 C for 1min,
using ReadyMix (Bio-Lab). The products were resolved
on a 2% agarose gel. PCR products were eluted from
gel and conﬁrmed by DNA sequencing after puriﬁcation
(Wizard, Promega). Every result represents at least three
independent experiments. The ratio of exon inclusion to
exon skipping was determined using the ImageJ tool.
RESULTS
Overlapping SR protein putative binding sites may result
in competitive inhibition between the two SR proteins for
binding to their corresponding sequences. Such competi-
tive inhibition might allow a delicate regulation of the
splicing process. If this scenario is common, we expected
functional overlapping motifs to be more abundant than
expected and perhaps over-conserved. In contrast, such
competitive inhibition might interfere with the proper
identiﬁcation of a nearby exon–intron junction. In these
cases, we could expect negative selection to act against
such overlapping motifs.
The putative binding sites of SR proteins tend to
signiﬁcantly overlap
To determine whether putative binding sites of SR
proteins have a positive or negative tendency to overlap,
we examined putative SR-binding sites that had been
experimentally identiﬁed by SELEX (31–33); we did not
analyze bioinformatically identiﬁed putative elements
because were concerned they could be sequence-biased.
We developed a method to examine whether two
SR putative binding sites that can overlap do so.
For example, the putative SRp55-binding sequence TGC
AGA may overlap with the putative SF2-binding sequence
CAGACGA in the context of TGCAGACGA. Brieﬂy, we
calculated the expected frequency of the uniﬁed sequence
(TGCAGACGA) in the human exons dataset, given the
prevalence of the ﬁrst sequence (TGCAGA) and of the
extension (CGA). Estimates were based on the relative
frequency of the four nucleotides (A, C, G and T) in
each of the possible three phases of the codon (0, 1 and
2). This was done to avoid any bias that may be
introduced by protein coding constraints. The expected
frequency was then compared with the observed frequency
of the uniﬁed sequence and putative binding sites that
were signiﬁcantly over-abundant or under-represented
were identiﬁed.
First, we generated a pool of all possible hexamers,
heptamers and octamers previously identiﬁed as putative
SR-binding sites using any of the ﬁve available matrices in
the ESEﬁnder web server (SRp55, SRp40, SF2/ASF, SF2/
ASF BRCA1 and SC35; using threshold of four to
maximize credibility) (34). We then calculated all the the-
oretical possibilities for overlap (i.e. all possible uniﬁed
sequences, 192327 cases). Since we were interested in iden-
tifying cases of potential interaction/competitive inhibi-
tion between two diﬀerent SR proteins, we discarded
uniﬁcations that involved two putative binding sites of
the same SR protein as such cases might actually reﬂect
one longer binding site for a single SR protein (for a
separate analysis of these sequences see Supplementary
Table S2). Next, we extracted a dataset containing
202839 human RefSeq exons. We discarded exons for
which we could not extract the deﬁnite phase (e.g. exons
in intronless genes, exons in the UTR, etc.) and very short
or very long exons (top and bottom 0.025%); 150941
exons remained. We examined the coding sequence of
each exon and calculated the prevalence of each of the
four nucleotides (A, C, T and G) in each of the three
possible codon phases (0, 1 and 2).
In the next step, we calculated the expected frequency of
all uniﬁed sequences. We examined the exons in the
dataset to identify the prevalence of each putative
binding site in each of the three phases. For example,
the putative SRp55 TGCAGA sequence appeared 1086,
6503, 6046 times in phases 0, 1 and 2, respectively. Using
the nucleotide frequency table in each of the phases we
then calculated the expected prevalence of the uniﬁed
sequence as follows:
X 2
phaseS¼0
ObsðSeq1jphaseSÞ 
Y X
E¼1
FreqðNuc½E jphaseNÞ
 !
ð1Þ
where phaseS is 0, 1, or 2 and Obs(Seq1|phaseS) is the
prevalence of Seq1 in the speciﬁc phaseS; X is the number
of extending nucleotides (three in the above example);
E ranges from 1 to X, and represents a speciﬁc extending
nucleotide (E=1,2,3 for the extending nucleotides
C,G,A, respectively); and Freq(Nuc[E]|phaseN) is the fre-
quency of the extending nucleotide in position E, which is
in phaseN.
After calculating the expected frequency for all possible
uniﬁed sequences, we analyzed the dataset of exons to
retrieve observed frequencies. For each of the uniﬁed
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jected to a Fisher’s exact test and false discovery rate
(FDR; P-value<0.05) correction for multiple testing
(35). This way, we identiﬁed potential overlapping
binding sites that were signiﬁcantly over-abundant or
under-represented. Out of the 192327 possible uniﬁcations
of putative overlapping binding sites, we found 72 uniﬁed
sequences that were signiﬁcantly over-abundant and
153 that were signiﬁcantly under-represented (see
Supplementary Table S1 for the speciﬁc overlaps).
Several SR protein-binding sites have a signiﬁcant
tendency to overlap. However, this phenomenon may
not be unique to splicing regulatory sequences. It may
be that any similar subset of sequences would exhibit the
same tendency to overlap, yielding similar numbers of
over-abundant and under-represented overlaps. In order
to address this issue, we generated 100 random subsets of
sequences, which were not detected as splicing regulatory
elements by any of the ESEﬁnder matrices (33,34) nor by
other known bioinformatic detection methods (15,36,37).
Each random subset was composed of the same number of
hexamers, heptamers and octamers as the original dataset.
Next, we performed the same statistical analyses to reveal
signiﬁcant overlaps between the random sequences in each
of the 100 random subsets. We found that the number
of signiﬁcant over-abundant and under-represented
SR-binding site overlaps was signiﬁcantly higher than
the one observed for all 100 random datasets containing
splicing inert sequences (P<0.01 for both the
over-abundant and under-represented sequences).
We were also interested to examine whether the
SR-binding sites that form the over-abundant and
under-represented overlaps tend to appear in proximity,
even if not in overlap. If so, their tendency to appear in
overlap could be only a special case of their general
tendency to be in proximity. We examined the average
distance between every two SR-binding sites that formed
an overlapping motif. This average distance was
calculated for all SR-binding sites that formed a
signiﬁcantly over-abundant or under-represented
overlapping motif. As control, we calculated the average
distance between every two SR-binding sites that did not
form over-abundant or under-represented overlapping
sites. We found that the average distance between
the putative SR-binding sites that form an over-abundant
or an under-represented overlapping motif did not
signiﬁcantly diﬀer from the control dataset (see
Supplementary Figure S1). This suggests that the
overlapping motif itself is important and that the results
we found could not be explained by mere proximity
between SR-binding sites.
Comparative analysis revealed high conservation of
over-abundant motif overlaps
We identiﬁed 72 signiﬁcantly over-abundant and 153
signiﬁcantly under-represented overlapping SR protein
putative binding motifs. To shed light on the functionality
of these motif overlaps, we employed a comparative
genomics approach. The common premise underlying
comparative genomic analyses is that selective pressure
dictates that functional elements evolve at a slower rate
than that of non-functional sequences. Indeed, splicing
regulatory elements were shown to be highly conserved,
indicative of their signiﬁcance in splicing regulation
(38,39). To examine the conservation level of the signiﬁ-
cant overlaps we identiﬁed, we extracted a dataset of
human exons and their conserved orthologs (>75%
nucleotide identity) in mouse (Mus musculus), rat (Rattus
norvegicus), cow (Bos taurus), dog (Canis familiaris),
chicken (Gallus gallus) and zebraﬁsh (Danio rerio).
We then calculated the percentage of over-abundant and
under-represented SR motif overlaps that were fully
conserved (no mismatches allowed) between the human
exons and their orthologous counterparts. As control for
the signiﬁcantly over-abundant (or under-represented)
motifs, we used all overlap motifs that appeared more
(or less) than expected albeit not signiﬁcantly. As
illustrated in Figure 2, compared to the non-signiﬁcant
motifs, the 72 over-abundant overlapping motifs we
identiﬁed are signiﬁcantly conserved between
human exons and their orthologous counterparts in
mouse (P=4.77e 60), rat (P=1.68e 32),
cow (P=4.72e 18), dog (P=1.62e 04), chicken
(P=6.05e 07) and zebraﬁsh (P=3.13e 03,  
2 with
df=1 for all tests). Examination of the 153
under-represented motifs overlaps revealed insigniﬁcant
results. We were concerned that some of the mismatches
we identiﬁed do not actually change the ability of the
sequence to function as a binding platform for the corre-
sponding SR protein, i.e. the k-mer including the
mismatch still belongs to the same SELEX matrix. We
therefore repeated this analysis, this time considering
mismatches that still preserve the ‘binding-type’ (giving
ESEﬁnder motif score higher than the threshold) as
conserved. However, this analysis yielded similar results
(see Supplementary Data).
We next employed another statistical approach to
conﬁrm the validity of the conservation level of
the over-represented motifs. Under the assumption that
two adjacent N-mers are independent, the expected con-
servation level of each overlapping SR-binding motifs
could be calculated based on three observations: (i) the
conservation level of the putative SR-binding site,
Cons(SRbinding); (ii) the conservation level of the corre-
sponding extension of N-mers, Cons(extension) and
(iii) the number of times the corresponding overlap
was detected in the dataset, Occurrence
(SRbinding+extension), as follows:
ConsðSRbindingÞ ConsðextensionÞ
  OccurenceðSRbinding þ extensionÞ:
ð2Þ
After calculating the expected conservation level of each
overlapping sequence in the orthologous exons between
human and each of the other examined species, we
examined these exons to extract the actual conservation
level of each of the overlapping motifs. For example, the
overlap TGACTCCAG is comprised of the
SRp40-binding site TGACTCC and of the extension
AG, which is derived from the SR-binding site SC35 (G
ACTCCAG). The expected conservation level of this
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calculated by multiplying the conservation level of the
SRp40-binding site (40%, for example) and the conserva-
tion level of the extension AG (77%, for example). The
result was then multiplied by the number of times we
observed this overlap in the data (128 times, for
example) resulting in 39.22—the expected conservation
level for the overlap TGACTCCAG.
Generally, the over-abundant motifs were signiﬁcantly
conserved between human and mouse (P=2.90e 04),
rat (P=3.60e 03), cow (P=4.88e 03) and chicken
(P=5.14e 03), but were not signiﬁcantly conserved
between human and dog (P=0.19) or human and
zebraﬁsh (P=0.89,  
2 with df=1 for all tests).
Examination of the 153 under-represented motif
overlaps revealed signiﬁcant, yet opposite results. These
motifs were signiﬁcantly less conserved between human
and mouse (P=2.40e 17), rat (P=8.34e 08), cow
(P=1.62e 04) and zebraﬁsh (P=0.043), but not
between human and dog (P=0.48) or human and
chicken (P=0.13,  
2 with df=1 was used for all tests).
Overall, we used diﬀerent methods to examine the
conservation level of the over-abundant and
under-represented motifs (see Supplementary Data for
another method). The results imply that the
over-abundant motif overlaps we identiﬁed are function-
ally relevant. These over-abundant motifs are signiﬁcantly
conserved despite millions of years of evolution since the
last common ancestor of the organisms evaluated, suggest-
ing that these motif overlaps play a functional role in the
regulation of splicing. In contrast, under-represented
motif overlaps were not signiﬁcantly conserved
compared to the random data or even exhibit a signiﬁcant
opposite trend. This suggests that the under-represented
Figure 2. Conservation of the over-abundant overlapping regulatory binding motifs. The conservation levels of the overlapping motifs were
calculated between orthologous exons of human and (A) mouse, (B) rat, (C) cow, (D) dog, (E) chicken and (F) zebraﬁsh. These calculations
were performed for both signiﬁcant (light-gray bars) and control (dark-gray bars) overlaps. The percent conservation level (y-axis) is indicated
for both the over-abundant and the under-represented overlapping motifs (x-axis).
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with the splicing process.
Abundance of SR overlapping binding motifs correlates
with splice signal strengths
We next examined whether the abundance of SR
overlapping binding motifs in exons correlated with the
strength of the splice sites. The splicing signals play a
major role in the proper recognition of the exon/intron
junctions. For example, the strength of the aﬃnity of U1
snRNA to the 50 splice site dictates both constitutive and
alternative splicing, as well as regulates the inclusion/
skipping ratio in alternative splicing (40). However, the
presence of a strong ESE can compensate for a weak
splice site (41). Thus, if the over-abundant SR overlapping
binding sites are indeed functional in splicing regulation,
we would expect them to be more abundant in exons with
weak splice signals. Similarly, if the under-represented SR
overlapping binding sites interfere with the splicing
process, we would expect them to be selected against, espe-
cially in exons with weak splice signals.
To test these hypotheses we divided our exon dataset
into quartiles according to either their 50 splice site or their
30 splice site strength, as computed by the MaxEntScan
server (42). We deﬁned strong or weak exons according to
their presence in the upper or lower quartile, respectively.
Next, for each of the exons, we determined the number of
nucleotides that were part of a motif overlap and the
number of nucleotides that were not (omitting the ﬁrst
and the last three bases as these are part of the splice
signals). The over-abundant overlapping motifs were
signiﬁcantly more abundant in exons with weak 50 splice
site splice signals than in exons with strong ones
(P=3.77e 20,  
2 with df=1). Furthermore, we found
that the under-represented overlapping motifs were
signiﬁcantly selected against in exons with weak 50 splice
site splice signals compared to exons with strong ones
(P=2.70e 10,  
2 with df=1). Similar results were
obtained when exons were classiﬁed according to their
30 splice site strengths. Namely, over-abundant motifs
were found mainly in exons with weaker splice signals
whereas under-represented motifs were selected against
in this group of exons (over-abundant P=1.69e 34;
under-represented P=1.46e 26,  
2 with df=1).
Negative selection acts against the under-represented
sequence overlaps near the splice donor site
The above analyses implied that under-represented
sequences interfere with the splicing process as they are
selected against. Previous studies indicated that the
density of exonic splicing regulatory elements is highest
near splice sites and that the relative location of these
elements is crucial for their function (36,38,43).
Furthermore, it appears that the eﬀect of exonic splicing
regulatory sequences is more prominent near the splice
donor site than the splice acceptor site (36). Thus, if the
under-represented overlapping motifs we identiﬁed indeed
interfere with the splicing process, we could expect
they would be selected against speciﬁcally near the splice
donor site where they would interfere most with splice
site selection. Furthermore, we could expect such a phe-
nomenon to be more prominent in exons with weaker
splice signals, which are sub-optimally recognized to
begin with, and hence depend more on auxiliary splicing
factors.
To reveal correlations between the strength of the splice
signals and the distribution of the under-represented SR
putative binding motif overlaps along the exons, we
divided the sequence of each of the exons into quartiles.
The ﬁrst and last quartiles were near the splice acceptor
and donor site, respectively. As above, for each of the
exons, we determined the number of nucleotides that
were part of a motif overlap and the number of
nucleotides that were not (omitting the ﬁrst and the last
three bases of each exon, as these are part of the splice
signals). We subdivided the exons into those with strong
or weak 50 and 30 splice sites (see above). There was a
signiﬁcant diﬀerence between the distributions of
under-represented overlapping motifs across the entire
exon for exons with strong versus weak 50 splice sites
(P=3.20e 35,  
2 with df=3; see Figure 3A). This dif-
ference in the distribution was observed mainly near the
splice donor site. Similarly, there was a signiﬁcant diﬀer-
ence between the distributions of under-represented
overlapping motifs across the entire exon for exons with
strong versus weak 30 splice sites (P=2.08e 05,  
2 with
df=3; see Figure 3B). Again, this diﬀerence was found to
be more prominent near the splice donor site.
Diﬀerent spatial distributions of over-abundant and
under-represented overlaps in exons with weak 50 splice
sites
The results indicated that over-abundant overlaps are
functionally important and play a regulatory role in the
splicing process. If the over-abundant motifs indeed par-
ticipate in splicing regulation, we would expect their dis-
tribution along exons to be diﬀerent from the distribution
of the under-represented motifs. Namely, we expect their
prevalence to be higher near the splice donor site. Our
data indicated that the relative distribution of
over-abundant and under-represented motifs is
signiﬁcantly diﬀerent. The under-represented motifs are
highly selected against and over-abundant motifs are
highly preferred speciﬁcally near weak 50 splice sites
(Figure 4; P=2.56e 51,  
2 with df=1). In fact, in
exons with a strong 50 splice site, there was no signiﬁcant
preference for either type of motifs. These results suggest
that exons with weak splice signals that rely on auxiliary
factors for their splicing are more aﬀected by the presence
or absence of the over-abundant and under-represented
motifs; in these exons, the motifs are under tight selective
pressure.
Over-abundant motif overlaps facilitate a new mode of
splicing in a reporting minigene system
The above bioinformatic ﬁndings suggest that overlapping
splicing regulatory sequences can positively or negatively
interact to aﬀect splicing. Speciﬁcally, we found
72 signiﬁcantly over-abundant and conserved overlaps,
suggesting they may be functional in splicing regulation.
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we examined four representative over-abundant overlaps
in a minigene reporting system (44). The minigene was
composed of four exons, and we inserted the tested
overlapping motif into the second exon. For each
overlap, which is comprised of two splicing regulatory
motifs (seq1 and seq2), we designed one mutation to elim-
inate seq1 leaving seq2 intact, and one mutation to elim-
inate seq2 leaving seq1 intact. We introduced each of the
two mutations to the minigene independently to test the
eﬀect of the presence of seq2 or seq1 alone. We then also
introduced the two mutations simultaneously to test the
eﬀect of the absence of both sequences. Two of the four
overlaps we tested showed full exon skipping, a pattern
that did not change regardless of the mutations we
introduced (data not shown). However, the other two
overlaps enabled a mode of splicing that did not occur
in the presence of only one of the two regulatory
sequences that comprise it, nor did it occur in the
absence of the entire overlap (the overlaps’ sequence is
indicated in Supplementary Table S1). The insertion of
the ﬁrst overlap resulted in 80% inclusion level, while
mutations that eliminated each of the regulatory
sequences that form the overlap, or eliminated them
both, resulted in diﬀerent splicing patterns (30, 67 and
0%, respectively; Figure 5, complex I). The insertion of
the second overlap resulted in 13% inclusion level.
Similarly, mutations that eliminated each of the regulatory
sequences that form the overlap, or eliminated them both
yielded diﬀerent splicing patterns (59, 71 and 0%, respec-
tively; Figure 5, complex II). These experimental results
are consistent with the possibility that the overlapping
splicing regulatory motifs provide regulation that is diﬀer-
ent from the eﬀect of each regulatory sequence alone.
However, it is worth noting that further experimental
analysis is required to determine this matter, as it may
be that the extension itself is important, rather than the
relation between two diﬀerent splicing factors.
DISCUSSION
To date, many layers of splicing regulation have been doc-
umented. These include the consensus splice site
sequences, auxiliary signals, such as exonic and intronic
enhancers and silencers [reviewed in ref. (40)], chromatin
structure and transcription elongation rate (45). However,
despite a vast body of knowledge on elements and
sequences that aﬀect splicing of particular genes, the
splicing code in general is far from being fully understood
and one cannot predict the mode of splicing of a given
exon (or an intron) strictly from analysis of sequence.
In this work we provide evidence that two exonic
splicing regulatory sequences that overlap might represent
Figure 4. Comparison between the distributions of over-abundant and
under-represented motifs along exons. The distribution of the
over-abundant (light gray bars) and under-represented (dark gray
bars) sequence overlaps along exons was calculated for exons with
(A) strong 50 splice signals and (B) weak 50 splice signals. Exon
sequences were divided into four equally sized quartiles (x-axis). The
percentage of nucleotides which are part of over-abundant or
under-represented motif overlaps in each of the four quartiles is
indicated (y-axis).
Figure 3. Distribution of under-represented motifs along exons. The
distribution of the under-represented motif overlaps along exons was
calculated for exons with strong (light-gray bars) and weak (dark-gray
bars) splice signals near (A) the 50 splice signal and (B) the 30 splice
signal. Exon sequences were divided into four equally-sized quartiles
(x-axis). The percentage of nucleotides which are part of
under-represented motif overlaps, in each of the four quartiles, is
indicated (y-axis).
3324 Nucleic Acids Research, 2010,Vol.38, No. 10yet another level of splicing regulation. We describe a
computational method, based on the natural distribution
of nucleotides and splicing regulatory sequences, by which
we identiﬁed overlapping putative splicing regulatory
sequences. Dozens of such motif overlaps are favorable
in exons and even more appear to be selected against,
implying both positive and negative interplay between
splicing regulatory motifs. Selection against overlap of
regulatory sequences might not be surprising. Such
overlapping motifs, which are presumably formed by
two independently functional regulatory binding sites,
may obstruct one another when in overlap resulting in
improper splicing. On the other hand, we were surprised
that some motifs have a speciﬁc and signiﬁcant tendency
to overlap. This ﬁnding implies that there is a layer of
splicing regulation provided by a competition between
factors that can either assist or obstruct the splicing
machinery in proper recognition of exon/intron junctions.
Such a competition could depend on the strength with
which each SR protein binds to its speciﬁc regulatory
sequence, the expression levels of the SR proteins, their
level of phosphorylation, or their spatial distribution
within the cell, which could vary in diﬀerent cell types or
cell stages (see also Figure 1). The outcome of such com-
petition could result in the proper splicing mode (consti-
tutive or alternative), or proper exon inclusion level, in
each cell type or stage. It is worth noting that the
complexes we identiﬁed might in fact reﬂect single longer
motifs, however, our data provides evidence against such
possibility (see Supplementary Data and Supplementary
Figure S2).
By using comparative genomics we showed that the
over-abundant overlapping splicing regulatory motifs are
highly conserved among human and six other species. This
suggests an important functional role for these
overlapping motifs in splicing regulation, as they are
signiﬁcantly conserved despite the  450-million years of
evolution since the last common vertebrate ancestor. The
overlapping motifs we found to be under-represented were
not conserved. In fact, in some species, these overlapping
motifs were actually signiﬁcantly less conserved than
expected, suggesting that selective pressure acts against
them. Therefore, such overlapping motifs have been
selected against and eliminated during evolution.
We further showed that the prevalence of over-
abundant SR overlapping binding motifs in exons corre-
lates with the strength of splice signals. Over-abundant
overlapping motifs were signiﬁcantly more abundant
in exons with weak donor/acceptor splice signals than in
exons with strong ones. This suggests that this addi-
tional level of regulation introduced by the overlapping
motifs is speciﬁcally important for exons with
suboptimal splicing signals for which splicing regulation
depends strongly on auxiliary splicing factors. The preva-
lence of the under-represented overlapping motifs was
negatively correlated with the strength of the splice
signals. Exons with suboptimal splice signals are more
prone to undergo aberrant splicing than those with
consensus signals and therefore may be less permissive
to the presence of sequences that obstruct the splicing
process.
Additional examination of the overlapping motifs
revealed that over-abundant and under-represented
motif overlaps exhibited diﬀerent spatial distributions. In
exons with weak splice donor sites but not in those with a
strong donor splice site, under-represented motifs were
relatively less prevalent near the splice donor site than
over-abundant motif overlaps. This implies that
over-abundant and under-represented motif overlaps
functionally diﬀer. We hypothesize that the
over-abundant motifs we identiﬁed take part in ﬁne
tuning the delicate splicing regulation and that the
under-represented motifs hinder the splicing machinery
and are therefore selected against. Finally, to further
support the bioinformatic ﬁndings, we experimentally
tested selected over-abundant overlaps in a minigene
reporting system. We revealed that the overlaps enabled
a mode of splicing that did not occur when either of the
splicing motifs that form the overlap was present
independently, nor did it occur when the entire overlap
was absent. While our analyses reveal the over-abundance
and conservation of overlapping sequences, both of which
are indicative of functional implications, further experi-
mental work is needed to determine whether there is
actual binding of the SR-proteins to these speciﬁc sites.
Overall, the results we present are indicative of another
dimension of splicing regulation that involves overlapping
splicing regulatory motifs.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 5. The eﬀect of two over-abundant overlaps in a minigene
reporting system. Each tested overlap was inserted into the second
exon of a reporting minigene comprised of four exons.
(A) Illustration of an overlap comprised of two spicing regulatory
sequences. Seq1 is in light-gray, seq2 is in black, and the overlapping
sequence is in dark-gray. For each overlap, which is comprised of two
splicing regulatory motifs (seq1 and seq2), we introduced two muta-
tions: (B) mutation to eliminate seq1 leaving seq2 intact, and
(C) mutation to eliminate seq2 leaving seq1 intact. (D) Insertion of
both mutations simultaneously. (E) Splicing patterns of each of the
two overlaps (overlap I: lanes 1–4; and overlap II: lanes 5–8) is
depicted. For each overlap, the splicing pattern in its presence, after
the elimination of seq1, the elimination of seq2, or the elimination of
both is depicted, respectively. The upper bands indicate exon inclusion,
while the lower bands indicate exon skipping; the exact inclusion level
is indicated above each lane.
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